MEMSCAP (MEMS) - RN 2023 / Prochaine étape, 2026 ! - Achat - 10,3 € vs 8,6 € - Pot. +12,7%
- CA 2023 +50,7% à 14,1 M€ ;
- Marge Ebitda 23,2% vs 15,5% en 2022 / Marge opérationnelle 17,6% vs 2,5% en 2022 / Marge nette 15,2% vs 1,6% en 2022 hors Communications Optiques ;
- Liquidités disponibles 6,24 M€.
Memscap. Memscap SA is a France-based company engaged in the provision of solutions based on micro-electromechanical systems (MEMS) technology. The Company operates in four market segments: Aerospace, Medical / Biomedical, Mass Market / Other Applications, and Optical Communications / Adaptive Optics. The Company's products include pressure sensors, pressure transducers, pressure switches, medical accessories, optical attenuators (chips), micro relays and Multi-User MEMS Processes, such as PolyMUMPs, SOIMUMPs, MetalMUMPs, and PiezoMUMPs. The Company's customers include Fortune 500 businesses, major research institutes and universities. The Company's wholly owned subsidiaries include Laboratoires La Licorne SAS (France), MEMSCAP Inc (the United States) and MEMSCAP AS (Norway).
The independent financial analysis dedicated to Small & Mid Caps. Established in 2011, GreenSome Finance specializes in independent financial analysis and financial advice to SMEs, listed and unlisted. Our role is to support managers in their strategy of value creation.
Our jobs:
- Equity analysis and institutional marketing
- Establishment and validation of business plan
- Expertise and independent business valuation
Our strengths:
- A historic and recognized skills on the Small Cap market
- An entrepreneurial culture that combines a customized offer, proximity and reactivity
- A structure certified Listing Sponsor and Analysts members of the SFAF (French Society of Financial Analysts)
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.